Red Rock Regeneration secures first spot in Deloitte Canada's 2025 Technology Fast 50 program category

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Red Rock Regeneration Inc. tops Deloitte Canada's 2025 Technology Fast 50 category, posting an extraordinary three-year revenue growth rate of 12,166%. This achievement highlights the company's rapid expansion and underscores the strength of Canadian innovation. Headquartered in Etobicoke, Red Rock Regeneration is a pioneer in regenerative medicine.

Red Rock Regeneration is an OBIO® member.

Read more
Arsheen Kaur
Previous

AmacaThera signs exclusive global licensing agreement with Pacira BioSciences for upto US$230M
Next

Conavi Medical announces agreement with the Province of Ontario as part of LSSUF